GOOD START SUPREME SOY DHA & ARA OTC
Generic Name and Formulations:
Protein (enzymatically hydrolyzed soy protein isolate), carbohydrate (corn maltodextrin, sucrose), fat (palm olein, soy, coconut, high-oleic safflower or high-oleic sunflower, c. cohnii, m. alpina oils), iron 1.8mg/100Cal, vitamins, minerals, L-carnitine, L-methionine, taurine, nucleotides 3mg/100Cal, ARA, DHA.
Indications for GOOD START SUPREME SOY DHA & ARA:
Feeding of infants up to 12 months of age with cow's milk protein sensitivity, lactose intolerance, or galactosemia.
Prepared as directed provides 20Cal/oz.
Infant formula with iron (soy-based).
Pwd—12.9oz, 25.7oz; Ready-to-feed—32oz; Conc—13oz
Clinical Pain Advisor Articles
- Abuse-Deterrent Opioid Formulations: Barriers to Broader Use
- Women Frequently Prescribed High Doses of Opioids After Vaginal Delivery
- Notifications by PDMPs May Not Effectively Reduce Opioid Misuse
- Virtual Reality May Effectively Reduce Sensory, Affective, and Cognitive Pain During Labor
- Electroacupuncture May Help Reduce Opioid Use in Chronic Musculoskeletal Pain
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Ketamine Infusions May Be Effective for Refractory Headache
- Physical, Psychosocial Activity May Be Protective Against Development of Chronic Pain in Older Adults
- Opioid Use Disorder Prevalence at Delivery on the Rise in the US, According to CDC
- Suprazygomatic Sphenopalatine Ganglion Block May Quickly Relieve Status Migrainosus Pain
- Pharmacologically Induced Headache Accompanied by Dilated Cephalic Vessels
- IV Lidocaine May Be Safe, Efficacious for Pediatric Status Migraine
- Gray Matter Changes in Migraine Associated With Clinical Characteristics